Microchip Controlled Subcutaneous Drug Delivery Devices
|出版商||Greystone Research Associates||商品編碼||558552|
|微晶片控制的皮下藥物輸送設備 Microchip Controlled Subcutaneous Drug Delivery Devices|
|出版日期: 2017年09月26日||內容資訊: 英文||
As therapeutic drug markets continue to evolve, advancements in drugs and devices are producing several positive improvements. New formulations are extending drug release profiles, leading to less frequent dosing. Enhancements in syringe and injector usability are increasing the number and types of therapeutics that can be self-administered. These advances have revealed a new set of concerns. Weekly, bi-weekly and monthly dosing deprives the patient of the repetitive reinforcement that is a key tenet of self-injection safety at a time when the dangers associated with powerful drug side effects are placing a priority on the need for accurate dosing and delivery. In response, device suppliers have been developing syringes and injectors with new technology, adding capabilities that address self-administration safety concerns. Using innovative technical solutions, these device features decrease patient reliance on recall, guiding them through the medication process and reducing the risk of drug dosing errors.